Lysosomal protein catabolic process

pathway activity & survival
GO:1905146SurvivalRNA activityKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNA activity of the Lysosomal protein catabolic process pathway is associated with patient survival in 18 of 34 cancer lineages. Pathway activity is summarized from the expression of its 19 member genes.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher Lysosomal protein catabolic process pathway activity is associated with better overall survival. In most high-consensus cancer types, elevated pathway activity shows an unfavorable survival association, although some cancer types, such as LUAD and UCS, show the opposite pattern, with higher activity associated with better survival.

LUAD, THCA, and UCS are the cancer lineages in which this pathway most reproducibly stratifies patient survival.

Pathway-activity survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 represent the survival AUCs for the high- and low-pathway-activity groups, respectively. The group with the lower AUC is interpreted as having poorer survival. The reported p-values are derived from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LUADOSTertileII,III,IV0.8160.633.00546view →
THCAOSMedianII,III,IV0.9570.993.00331view →
UCSDFSTertileIV0.8600.239.02430view →
BLCAOSQuartileIII,IV0.7280.367.01420view →
TGCTDFSTertileAll0.9800.735<.00118view →
MESOOSTertileIV0.1560.719.00118view →
DLBCDFSMedianIV0.1281.000.01717view →
KIRCDFSMedianIII,IV0.5400.710.01017view →
KIRPDFSMedianAll0.9750.798.00716view →
READOSMedianII,III,IV0.7910.488.00713view →
SKCMDFSMedianAll0.7040.569.00912view →
LUSCOSTertileIII,IV0.2940.790.00612view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

GO:1905146–LUAD (OS)

Kaplan–Meier survival curve for Lysosomal protein catabolic process pathway activity in LUAD.

Open the LUAD breakdown →

Exploration